2021 Q3 Form 10-Q Financial Statement

#000156459021045192 Filed on August 19, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q4
Revenue $709.1K $188.3K $40.00K
YoY Change 343.18% 44.82% -98.01%
Cost Of Revenue $469.6K $147.9K $20.00K
YoY Change 304.84% 78.23% -98.92%
Gross Profit $239.5K $40.33K $20.00K
YoY Change 398.92% -14.18% -87.5%
Gross Profit Margin 33.77% 21.42% 50.0%
Selling, General & Admin $1.382M $931.4K $930.0K
YoY Change 36.79% -19.71% -33.57%
% of Gross Profit 576.9% 2309.09% 4650.0%
Research & Development $0.00 $0.00 $70.00K
YoY Change
% of Gross Profit 0.0% 0.0% 350.0%
Depreciation & Amortization $7.650K $27.38K $0.00
YoY Change -31.98% -22.6% -100.0%
% of Gross Profit 3.19% 67.88% 0.0%
Operating Expenses $1.382M $931.4K $1.010M
YoY Change 36.79% 876.21% -25.19%
Operating Profit -$1.142M -$891.0K -$990.0K
YoY Change 18.72% 851.39% -16.81%
Interest Expense $8.120K -$4.837K -$70.00K
YoY Change 35.33% -169.1% 600.0%
% of Operating Profit
Other Income/Expense, Net -$4.620K -$2.059K $10.00K
YoY Change -192.4% -129.41% 0.0%
Pretax Income -$848.1K -$893.1K -$1.050M
YoY Change -11.66% 930.61% -11.76%
Income Tax $2.400K $0.00
% Of Pretax Income
Net Earnings -$850.5K -$893.1K -$1.050M
YoY Change -11.41% 930.61% -11.91%
Net Earnings / Revenue -119.94% -474.37% -2625.0%
Basic Earnings Per Share -$0.06 -$0.06
Diluted Earnings Per Share -$2.891K -$0.06 -$12.78K
COMMON SHARES
Basic Shares Outstanding 294.3M 13.92M
Diluted Shares Outstanding 14.72M 13.92M

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.59M $20.30M $4.136M
YoY Change 7894.3% 2206.53% -42.56%
Cash & Equivalents $10.58M $8.287M $4.136M
Short-Term Investments $7.007M $12.01M $0.00
Other Short-Term Assets $4.963M $3.524M $15.00K
YoY Change 368.22% 4250.96% -63.41%
Inventory $1.019M $1.860M $0.00
Prepaid Expenses $3.269M $1.083M
Receivables $746.6K $159.2K $13.61K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $24.32M $25.84M $1.939M
YoY Change 1356.09% 999.63% -79.88%
LONG-TERM ASSETS
Property, Plant & Equipment $430.6K $241.1K $227.6K
YoY Change -23.11% 97.17% 103.46%
Goodwill $49.55M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $173.6K $406.0K $242.0K
YoY Change -38.01% -48.15% -57.46%
Total Long-Term Assets $50.15M $50.19M $469.6K
YoY Change 5800.13% 5446.3% -31.04%
TOTAL ASSETS
Total Short-Term Assets $24.32M $25.84M $1.939M
Total Long-Term Assets $50.15M $50.19M $469.6K
Total Assets $74.47M $76.04M $2.409M
YoY Change 2855.07% 2235.95% -76.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $166.3K $234.4K $345.4K
YoY Change -74.02% -61.58% -17.37%
Accrued Expenses $864.6K $1.033M $2.383M
YoY Change -3.94% 41.12% 267.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $31.79K $298.8K $200.0K
YoY Change -80.13% 148.96%
Total Short-Term Liabilities $1.063M $1.566M $2.728M
YoY Change -37.12% 7.49% -60.39%
LONG-TERM LIABILITIES
Long-Term Debt $21.19K $45.30K $210.0K
YoY Change -91.85% -84.9%
Other Long-Term Liabilities $35.24K $388.9K $216.0K
YoY Change -86.45% 27.5% 45.95%
Total Long-Term Liabilities $56.43K $388.9K $216.0K
YoY Change -89.15% 27.5% 45.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.063M $1.566M $2.728M
Total Long-Term Liabilities $56.43K $388.9K $216.0K
Total Liabilities $1.119M $2.000M $2.881M
YoY Change -49.13% -2.85% -59.05%
SHAREHOLDERS EQUITY
Retained Earnings -$2.024M -$472.3K
YoY Change -96.71% -99.2%
Common Stock $2.940K $100.00
YoY Change 194.0% -90.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $73.35M $74.04M -$472.2K
YoY Change
Total Liabilities & Shareholders Equity $74.47M $76.04M $2.409M
YoY Change 2855.07% 2235.95% -76.65%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q4
OPERATING ACTIVITIES
Net Income -$850.5K -$893.1K -$1.050M
YoY Change -11.41% 930.61% -11.91%
Depreciation, Depletion And Amortization $7.650K $27.38K $0.00
YoY Change -31.98% -22.6% -100.0%
Cash From Operating Activities -$3.100M -$3.922M -$1.400M
YoY Change 98.71% 5502.27% -7.28%
INVESTING ACTIVITIES
Capital Expenditures $155.1K -$183.1K $0.00
YoY Change -1651.2%
Acquisitions
YoY Change
Other Investing Activities $5.000M -$12.00M $0.00
YoY Change 80.51% -24100.0% -100.0%
Cash From Investing Activities $5.155M -$12.18M $0.00
YoY Change 86.78% -24466.14% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.029M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 43.03K 16.13M 5.320M
YoY Change -100.8% 3834.99% 511.49%
NET CHANGE
Cash From Operating Activities -3.100M -3.922M -1.400M
Cash From Investing Activities 5.155M -12.18M 0.000
Cash From Financing Activities 43.03K 16.13M 5.320M
Net Change In Cash 2.098M 28.79K 3.920M
YoY Change -149.84% -92.62% 186.13%
FREE CASH FLOW
Cash From Operating Activities -$3.100M -$3.922M -$1.400M
Capital Expenditures $155.1K -$183.1K $0.00
Free Cash Flow -$3.255M -$3.739M -$1.400M
YoY Change 110.0% 5240.73% -7.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address Address Line1
EntityAddressAddressLine1
1215 Graphite Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Corona
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92881
dei City Area Code
CityAreaCode
951
dei Local Phone Number
LocalPhoneNumber
407-9860
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
ADOM
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
294317605
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001563568
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Security Exchange Name
SecurityExchangeName
NONE
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Entity File Number
EntityFileNumber
001-38078
dei Entity Registrant Name
EntityRegistrantName
ENVIROTECH VEHICLES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0774222
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
293959034
dei Amendment Flag
AmendmentFlag
false
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
159177
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
adom Class Of Warrant Or Right Exercisable Weighted Average Remaining Contractual Life
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractualLife
P3Y6M14D
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M21D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M9D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3M22D
dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8287286
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
254913
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1793910
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3269369
CY2021Q2 us-gaap Assets Current
AssetsCurrent
25841255
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1939132
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
241133
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
227561
CY2021Q2 us-gaap Goodwill
Goodwill
49546910
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
405999
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
242025
CY2021Q2 us-gaap Assets
Assets
76035297
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
234357
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
100
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
659059
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
88735
us-gaap Cost Of Revenue
CostOfRevenue
461366
us-gaap Cost Of Revenue
CostOfRevenue
73560
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
293959034
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
2940
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
76055926
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2023849
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-472260
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
74035017
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-472160
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76035297
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2408718
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Notes Payable Current
NotesPayableCurrent
298747
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1032991
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2382660
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1566095
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2728043
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
388887
CY2021Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
45298
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
152835
CY2021Q2 us-gaap Liabilities
Liabilities
2000280
CY2020Q4 us-gaap Liabilities
Liabilities
2880878
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-891020
adom Consulting Expense
ConsultingExpense
105358
adom Consulting Expense
ConsultingExpense
37300
CY2020Q4 us-gaap Assets
Assets
2408718
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
345383
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-472160
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-93655
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4837
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2778
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-239413
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1800582
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
82348
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-325417
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30166
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
188015
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22239279
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1422149
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
168791
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
931354
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
95405
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-5759
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2284
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2059
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3475
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-893079
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-86655
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1333289
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-183916
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
218300
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-893079
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-86655
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
58637619
us-gaap Net Income Loss
NetIncomeLoss
-1551589
us-gaap Net Income Loss
NetIncomeLoss
-183916
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-86655
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-183916
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
278431602
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
162757032
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6415110
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
53509622
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
156443
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-658510
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
16322049
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
31572
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-893079
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
74035017
us-gaap Profit Loss
ProfitLoss
-1551589
us-gaap Profit Loss
ProfitLoss
-183915
us-gaap Depreciation And Amortization
DepreciationAndAmortization
35376
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
10190
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
146804
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2243479
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1208657
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6817467
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
183076
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-265523
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-132502
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49990
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
12000000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-3373332
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8809744
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30166
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22737159
adom Related Party Investment
RelatedPartyInvestment
-49990
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
309865
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6612067
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-305593
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1930132
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
324055
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8542199
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18461
us-gaap Interest Paid Net
InterestPaidNet
2283
us-gaap Nature Of Operations
NatureOfOperations
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Organization and Operations</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Envirotech Vehicles, Inc. (“we”, “us”, “our” or the “Company”) is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. We serve commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles. Our vehicles address the challenges of traditional fuel price cost instability and local, state and federal regulatory compliance. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 15, 2021, the Company completed its acquisition of Envirotech Drive Systems, Inc., a Delaware corporation (“EVTDS”), a supplier of zero-emission trucks, cargo vans, chassis and other commercial vehicles. The transaction was completed in accordance with an Agreement and Plan of Merger, dated February 16, 2021 (the “Merger Agreement”), by and among the Company, EVTDS and EVT Acquisition Company, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). <span style="color:#000000;">See Note 3. </span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates<span style="font-weight:normal;font-style:normal;">—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
CY2021Q2 us-gaap Marketable Securities
MarketableSecurities
12010190
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
0
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2021Q2 us-gaap Inventory Net
InventoryNet
1860320
CY2020Q4 us-gaap Inventory Net
InventoryNet
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2021Q2 adom Inventory Deposits
InventoryDeposits
2877875
CY2020Q4 adom Inventory Deposits
InventoryDeposits
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
218300
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
218300
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-right:1.07%;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of Credit Risk<span style="font-weight:normal;font-style:normal;">—</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-right:1.07%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has credit risks related to cash and cash equivalents on deposit with a federally insured bank, as at times it exceeds the $250,000 maximum amount insured by the Federal Deposit Insurance Corporation (“FDIC”). Additionally, the Company maintains cash and short-term securities invested at Morgan Stanley Private Bank, National Association (“Morgan Stanley”). Between FDIC and the Securities Investor Protection Corporation (“SPIC”) coverage, funds up to $750,000, which may include cash up to $500,000, are insured. In addition, Morgan Stanley provides excess insurance acquired by them from SPIC for an additional $1.9 million in cash and unlimited per customer securities up to a $1 billion cap.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The restricted cash reported by EVTDS as of December 31, 2020, combined with additional cash raised in 2021, was used to fund both the merger closing requirement of $5,000,000 to ADOMANI, Inc. (see Note 3) and to repay liabilities of EVTDS. The amount of restricted cash and corresponding unpaid current liabilities of EVTDS that is included in the consolidated balance sheet at June 30, 2021 is approximately $<span>254,913</span>. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-right:1.07%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the three months ended March 31, 2021, total EVTDS sales were to one customer, ADOMANI, Inc., prior to the merger closing (see Note 3). The customer account was collected within two days of invoicing. In addition, the merged entity recorded additional sales during the two weeks post-merger which were made to two other customers and were collected within weeks of invoicing. The Company sold two vehicles during the last week of the three months ended June 30, 2021, and expects to be paid for them promptly and in full. Accordingly, customer accounts are reported at the invoiced amount outstanding.</p>
us-gaap Concentration Risk Credit Risk Financial Instrument Maximum Exposure
ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
250000
CY2021Q2 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
750000
CY2021Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
500000
adom Excess Insurance Acquired From Spic In Cash
ExcessInsuranceAcquiredFromSPICInCash
1900000
adom Unlimited Per Customer Securities Cap
UnlimitedPerCustomerSecuritiesCap
1000000000
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.14
adom Property Plant And Equipment Threshold For Capitalization Of Purchases
PropertyPlantAndEquipmentThresholdForCapitalizationOfPurchases
2000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
CY2021Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
188266000
CY2020Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
131590000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
363470000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
422047000
CY2021Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-893079000
CY2020Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-1191907000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-4195513000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-2557146000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
358802
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
252018
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
117669
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24457
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
241133
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
227561
CY2021Q1 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
0
CY2021Q2 us-gaap Depreciation
Depreciation
27380
us-gaap Depreciation
Depreciation
0
CY2020Q2 us-gaap Depreciation
Depreciation
35376
us-gaap Depreciation
Depreciation
0
CY2020 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
153668
CY2020Q1 us-gaap Foreclosed Assets
ForeclosedAssets
582000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12992857
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.29
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12398573
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.29
CY2021Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4029000
CY2021Q2 us-gaap Lease Deposit Liability
LeaseDepositLiability
11616
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
53735
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
255233559
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10681327
CY2021Q1 adom Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
2056326
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
29847994
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.09
CY2021Q3 adom Operating Lease Payment Exchange From Lease Obligation
OperatingLeasePaymentExchangeFromLeaseObligation
60630
CY2021Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
132949
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
190796
CY2020Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
46252
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
78104
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
150000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
96680
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Two And Three Years
OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears
53140
CY2021Q2 adom Employment Contracts Future Minimum Payments Due
EmploymentContractsFutureMinimumPaymentsDue
75000
CY2021Q2 adom Employment Contracts Future Minimum Payments Due Next Twelve Months
EmploymentContractsFutureMinimumPaymentsDueNextTwelveMonths
75000
CY2021Q2 us-gaap Contractual Obligation
ContractualObligation
225000
CY2021Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
171680
CY2021Q2 us-gaap Contractual Obligation Due In Second And Third Year
ContractualObligationDueInSecondAndThirdYear
53140
us-gaap Operating Lease Cost
OperatingLeaseCost
29487
CY2019Q2 adom Number Of Shares Refused To Release
NumberOfSharesRefusedToRelease
1320359
CY2019Q2 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
13500000.00
us-gaap Short Term Lease Cost
ShortTermLeaseCost
183515
us-gaap Short Term Lease Cost
ShortTermLeaseCost
78104
us-gaap Lease Cost
LeaseCost
213002
us-gaap Lease Cost
LeaseCost
78104
us-gaap Operating Lease Payments
OperatingLeasePayments
27906

Files In Submission

Name View Source Status
0001564590-21-045192-index-headers.html Edgar Link pending
0001564590-21-045192-index.html Edgar Link pending
0001564590-21-045192.txt Edgar Link pending
0001564590-21-045192-xbrl.zip Edgar Link pending
adom-10q_20210630.htm Edgar Link pending
adom-10q_20210630_htm.xml Edgar Link completed
adom-20210630.xsd Edgar Link pending
adom-20210630_cal.xml Edgar Link unprocessable
adom-20210630_def.xml Edgar Link unprocessable
adom-20210630_lab.xml Edgar Link unprocessable
adom-20210630_pre.xml Edgar Link unprocessable
adom-ex311_9.htm Edgar Link pending
adom-ex312_8.htm Edgar Link pending
adom-ex321_7.htm Edgar Link pending
adom-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending